Virtual, insurance-covered perimenopause and menopause care in all 50 states shows how fast a category can professionalize once someone builds the clinical and payer infrastructure it was missing.
Midi Health delivers virtual, insurance-covered care for perimenopause and menopause across all 50 states. Menopause is a universal life stage that medicine has treated, for decades, as an afterthought, undertaught in medical school and under-covered by insurance, largely left to patients to self-manage or seek out the small handful of specialists trained to treat it properly. Midi's rise is as much a story about building missing infrastructure as it is about clinical care itself.
National coverage from day one, not a regional pilot
Rather than launching city-by-city, Midi built toward all-50-state, insurance-covered coverage as the model itself, treating national scale as the starting point rather than a distant goal. That's a meaningfully different approach than most virtual care startups take, most of which prove a model in one or two states before slowly expanding, since building the clinical staffing and payer relationships needed for true national coverage from the outset is expensive and operationally complex. Midi's bet was that demand for competent menopause care was broadly and evenly distributed enough that a slow rollout would leave too much unmet demand on the table.
Menopause care has historically been under-taught in medical school and under-covered by insurance simultaneously, a structural gap Midi's model addresses on both sides at once.
Building the infrastructure medicine skipped
Medicine has largely ignored menopause as a distinct, clinically serious life stage for decades, leaving both training and reimbursement thin. Midi's contribution isn't a new treatment, it's the missing clinical and payer infrastructure that lets existing, well-established treatments actually reach patients at scale. That infrastructure-first framing also explains why the category has professionalized so quickly once someone built it, competitors now have a working national template to measure themselves against rather than starting from nothing.
Category maturity raising the bar for everyone else
Watch how quickly the broader menopause category, including newer entrants, converges toward the national, insurance-backed standard Midi has set, since that standard is quickly becoming the baseline rather than a differentiator. A new entrant today has to match national coverage and payer contracts just to be considered credible, a much higher starting bar than existed even two or three years ago. Whether smaller, regionally-focused competitors can survive against that baseline, or get absorbed by it, is worth tracking over the next few funding cycles.
